Effect of mammography screening and sociodemographic factors on stage of female breast cancer at diagnosis in New South Wales
Shannon Tong A , Matthew Warner-Smith A , Sarah McGill A , David Roder A B C and David Currow AA Cancer Institute NSW, Level 4, 1 Reserve Road, St Leonards, NSW 2065, Australia. Email: shannon.tong@health.nsw.gov.au; matthew.warnersmith@health.nsw.gov.au; sarah.mcgill@health.nsw.gov.au; david.currow@health.nsw.gov.au
B Cancer Epidemiology and Population Health, University of South Australia, Adelaide, SA 5001, Australia.
C Corresponding author. Email: david.roder@unisa.edu.au
Australian Health Review 44(6) 944-951 https://doi.org/10.1071/AH19124
Submitted: 30 May 2019 Accepted: 22 January 2020 Published: 17 November 2020
Abstract
Objective The aims of this study were to assess the effects of screening through BreastScreen NSW on the stage of cancer at diagnosis, and differences in cancer stage at diagnosis according to sociodemographic factors.
Methods Using linked BreastScreen NSW screening attendance records and NSW Cancer Registry data, the effects of screening participation and sociodemographic characteristics on stage at diagnosis were investigated using Kruskal–Wallis analysis of variance or the Mann–Whitney U-test for the 2002–13 diagnostic period. Multivariate logistic regression was used to investigate predictors of stage at diagnosis.
Results The association between BreastScreen NSW participation and earlier stage at diagnosis was strongest when the last screening episode occurred within 24 months of the cancer diagnosis, with an odds ratio of localised versus non-localised cancer of 1.61 (95% confidence interval 1.51–1.72). Women aged ≥70 years, Aboriginal women, residents of major cities and women living in areas of socioeconomic disadvantage were more likely to have distant than non-distant stage at diagnosis. A trend towards more distant stage in more recent diagnostic years was evident after adjusting for screening participation.
Conclusions The strongest and most consistent predictor of earlier stage at diagnosis was BreastScreen NSW participation. Continued efforts to increase screening participation are important to achieve earlier stage at diagnosis, particularly for sociodemographic groups with more advanced disease.
What is known about the topic? Earlier cancer stage at diagnosis is a prerequisite for mortality reduction from screening. Past research indicated that screening participation in New South Wales (NSW) was strongly associated with early stage at diagnosis and mortality reduction. More contemporary data are needed to monitor screening performance in NSW and assess differences in cancer stage across sociodemographic subgroups.
What does this paper add? Using data linkage, this paper indicates associations between screening, sociodemographic factors and stage at diagnosis for the NSW population in 2002–13. Contrary to expectations, major city residents tended to have a lower proportion of early stage breast cancer at diagnosis, which may be indicative of lower screening coverage and barriers to screening. Compared with past research, similar effects of screening and other sociodemographic factors on the stage of breast cancer at diagnosis were observed. This paper compares screening histories across sociodemographic groups, indicating statistically significant differences.
What are the implications for practitioners? Increasing screening participation is particularly important for sociodemographic groups who are diagnosed at more advanced stages, including women from lower socioeconomic areas, Aboriginal and Torres Strait Islander women and residents of major cities. In particular, the results reinforce the need to further develop targeted strategies to increase screening participation among NSW women from lower socioeconomic areas and Aboriginal and Torres Strait Islander women. Further investigation into screening coverage and barriers to screening for residents in major cities is needed.
References
[1] Cancer Council. Breast cancer screening. 2016. Available at: https://www.cancer.org.au/about-cancer/early-detection/screening-programs/breast-cancer-screening.html [verified 30 May 2018].[2] Taylor R, Morrell S, Estoesta J, Brassil A. Mammography screening and breast cancer mortality in New Wales, Australia. Cancer Causes Control 2004; 15 543–50.
| Mammography screening and breast cancer mortality in New Wales, Australia.Crossref | GoogleScholarGoogle Scholar | 15280633PubMed |
[3] International Agency for Research on Cancer (IARC). Breast cancer screening. IARC handbooks of cancer prevention, volume 7. Lyon: World Health Organization; 2002.
[4] Roder D, Houssami N, Farshid G, Gill G, Luke C, Downey P, Beckmann K, Iosifidis P, Grieve L, Williamson L. Population screening and intensity of screening are associated with reduced breast cancer mortality: evidence of efficacy of mammography screening in Australia. Breast Cancer Res Treat 2008; 108 409–16.
| Population screening and intensity of screening are associated with reduced breast cancer mortality: evidence of efficacy of mammography screening in Australia.Crossref | GoogleScholarGoogle Scholar | 18351455PubMed |
[5] Nickson C, Mason KE, English DR, Kavanagh AM. Mammographic screening and breast cancer mortality: a case-control study and meta-analysis. Cancer Epidemiol Biomarkers Prev 2012; 21 1479–88.
| Mammographic screening and breast cancer mortality: a case-control study and meta-analysis.Crossref | GoogleScholarGoogle Scholar | 22956730PubMed |
[6] Taylor RJ, Morrell S, Roder D. BreastScreen Australia evaluation. Mortality (ecological) study. Screening Monograph no. 4/2009; Canberra: Department of Health and Aging; 2009.
[7] Morrell S, Taylor R, Roder D, Robson B, Gregory M, Craig K. Mammography service screening and breast cancer mortality in New Zealand: a national cohort study 1999–2011. Br J Cancer 2017; 116 828–39.
| Mammography service screening and breast cancer mortality in New Zealand: a national cohort study 1999–2011.Crossref | GoogleScholarGoogle Scholar | 28183141PubMed |
[8] Elder K, Nickson C, Mann GB. ASO author reflections: impact of breast cancer screening beyond mortality reductions. Ann Surg Oncol 2018; 25 687–8.
| ASO author reflections: impact of breast cancer screening beyond mortality reductions.Crossref | GoogleScholarGoogle Scholar | 30414033PubMed |
[9] Bedrosian I. Screening mammography: getting to Version 2.0. Ann Surg Oncol 2018; 25 2500–1.
| Screening mammography: getting to Version 2.0.Crossref | GoogleScholarGoogle Scholar | 29796872PubMed |
[10] NSW Government, Cancer Institute NSW. NSW cancer registry. Sydney: Cancer Institute NSW; 2017. Available at: https://www.cancerinstitute.org.au/data-and-statistics/cancer-registries/nsw-cancer-registry [verified 30 April 2018].
[11] Noone AM, Howlader N, Krapto M, Miller D, Brest A, Yu M, Ruhl J, Tatolovich Z, Mariotta A, Lewis DR, Chen HS, Feuer EJ, Cronin KA, editors. SEER cancer statistics review (CSR), 1975–2015. Bethesda, MD: National Cancer Institute; 2018. Available at: https://seer.cancer.gov/archive/csr/1975_2015/ [verified 15 July 2019].
[12] Australian Bureau of Statistics (ABS). 2039.0 – Information paper: an introduction to Socio-Economic Indexes for Areas (SEIFA), 2006. Canberra: ABS; 2008. Available at: http://www.abs.gov.au/ausstats/abs@.nsf/mf/2039.0 [verified 30 April 2018].
[13] Australian Bureau of Statistics (ABS). 1216.0.15.003 – Australian Standard Geographical Classification (ASGC) remoteness area correspondences, 2006. Canberra: ABS; 2011. Available at: http://www.abs.gov.au/ausstats/abs@.nsf/products/1216.0.15.003~2006~main+Features~2006+RA+from+2006+SLA+Correspondence?OpenDocument##221227101023994955 [verified 30 April 2017].
[14] StataCorp LP. Stata statistical software release 13. College Station, TX: StataCorp LP; 2014.
[15] Tracey EA, Roder DM, Francis J, Zorbas HM, Hacker NF, Bishop JE. Reasons for improved survival from ovarian cancer in New South Wales, Australia, between 1980 and 2003: implications for cancer control. Int J Gynecol Cancer 2009; 19 591–9.
| Reasons for improved survival from ovarian cancer in New South Wales, Australia, between 1980 and 2003: implications for cancer control.Crossref | GoogleScholarGoogle Scholar | 19509555PubMed |
[16] Cancer Australia. National cancer control indicators. Distribution of cancer stage. Sydney: Cancer Australia; 2018. Available at: https://ncci.canceraustralia.gov.au/diagnosis/distribution-cancer-stage/distribution-cancer-stage [verified 10 July 2019].
[17] Lyle G, Hendrie GA, Hendrie D. Understanding the effects of socioeconomic status along the breast cancer continuum in Australian women: a systematic review of evidence. Int J Equity Health 2017; 16 182
| Understanding the effects of socioeconomic status along the breast cancer continuum in Australian women: a systematic review of evidence.Crossref | GoogleScholarGoogle Scholar | 29037209PubMed |
[18] NSW Government, Cancer Institute NSW. NSW cancer plan. Sydney: Cancer Institute NSW; 2011. Available at: www.cancerinstitute.org.au/cancer-plan [verified 22 June 2019].
[19] NSW Government, Cancer Institute NSW. Aboriginal communities. Sydney: Cancer Institute NSW; 2017. Available at: https://www.cancer.nsw.gov.au/cancer-plan/focus-areas/aboriginal-communities [verified 24 April 2019].
[20] Australian Institute of Health and Welfare (AIHW). BreastScreen Australia monitoring report 2018. Cancer Series no. 112. Catalogue no. CAN 116. Canberra: AIHW; 2018.
[21] Lauby-Secretan B, Scoccianti C, Loomis D, Benbrahim-Tallaa L, Bouvard V, Bianchini F, Straif K, for the International Agency for Research on Cancer Handbook Working Group Breast-cancer screening – viewpoint of the IARC Working Group. N Engl J Med 2015; 372 2353–8.
| Breast-cancer screening – viewpoint of the IARC Working Group.Crossref | GoogleScholarGoogle Scholar | 26039523PubMed |
[22] Seely JM, Hassan T. Screening for breast cancer in 2018 – what should we be doing today? Curr Oncol 2018; 25 S115–24.
| Screening for breast cancer in 2018 – what should we be doing today?Crossref | GoogleScholarGoogle Scholar | 29910654PubMed |
[23] Choi KS, Yoon M, Song SH, Suh M, Park B, Jung KW, Jun JK. Effect of mammography screening on stage at breast cancer diagnosis: results from the Korea National Screening Program. Sci Rep 2018; 8 8882
| Effect of mammography screening on stage at breast cancer diagnosis: results from the Korea National Screening Program.Crossref | GoogleScholarGoogle Scholar | 29892094PubMed |
